abiraterone ratiopharm 500 mg tabletti, kalvopäällysteinen
teva b.v. - abiraterone acetate - tabletti, kalvopäällysteinen - 500 mg - abirateroni
abiraterone stada 500 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - abiraterone acetate - tabletti, kalvopäällysteinen - 500 mg - abirateroni
abiraterone glenmark 500 mg tabletti, kalvopäällysteinen
glenmark arzneimittel gmbh - abiraterone acetate - tabletti, kalvopäällysteinen - 500 mg - abirateroni
abiraterone orion 500 mg tabletti, kalvopäällysteinen
orion corporation - abiraterone acetate - tabletti, kalvopäällysteinen - 500 mg - abirateroni
abiraterone accord
accord healthcare s.l.u. - abirateroniasetaatti - prostatiset kasvaimet - endokriinihoito - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - abirateroniasetaatti - prostatiset kasvaimet - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateroniasetaatti - prostatiset kasvaimet - endokriinihoito - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
androcur 50 mg tabletti
bayer oy - cyproteroni acetas - tabletti - 50 mg - syproteroni
vreya 0.035 mg / 2 mg tabletti, päällystetty
stragen nordic a/s - cyproterone acetate, ethinylestradiol - tabletti, päällystetty - 0.035 mg / 2 mg - syproteroni ja estrogeeni
cypretyl 2 mg / 35 mikrog tabletti, päällystetty
ratiopharm gmbh - cyproterone acetate, ethinylestradiol - tabletti, päällystetty - 2 mg / 35 mikrog - syproteroni ja estrogeeni